ARCHIVES

ODAC Meets at ASCO, Recommends Approval Of Dasatinib For CML.

This article is from The Cancer Letter archive.

Vol. 32 No. 22 | June 9, 2006

Download PDF Visit The Full Archive

Related Articles

ORI Final Findings Of Scientific Misconduct

September 16, 1994

NCI Supports New Cervical Cancer Screening Guideline

January 31, 2003

Arimidex Reduces Relapse Compared To Tamoxifen, Large Study Reports

December 28, 2001

NIH Acknowledges Role Of Pasteur Virus In AIDS Test, Gives France More Royalties

July 15, 1994

In Brief: Wittes To Become Acting DCT Director; Kaufman Leaves NCI For Private Practice

February 17, 1995

New Subcommittee Chairman Named

June 10, 1977